(5Z)-2-Amino-5-[(2-methoxyphenyl)methylidene]-1-methyl-4,5-dihydro-1H-imidazol-4-one

Catalog No. :
ACBLHP857
CAS No. :
855157-78-7
Molecular Formula :
C12H13N3O2
Molecular Weight :
231.26

IUPAC Name:(Z)-2-amino-5-(2-methoxybenzylidene)-1-methyl-1,5-dihydro-4H-imidazol-4-one

(5Z)-2-Amino-5-[(2-methoxyphenyl)methylidene]-1-methyl-4,5-dihydro-1H-imidazol-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5Z)-2-Amino-5-[(2-methoxyphenyl)methylidene]-1-methyl-4,5-dihydro-1H-imidazol-4-one
IUPAC Name(Z)-2-amino-5-(2-methoxybenzylidene)-1-methyl-1,5-dihydro-4H-imidazol-4-one
MDL No.MFCD03787857
Molecular FormulaC12H13N3O2
Molecular Weight231.26
SMILESO=C1N=C(N)N(C)/C1=C\C2=CC=CC=C2OC
InChI KeyGCCSPQAQOXMVFO-CLFYSBASSA-N
Synonym(5Z)-2-amino-5-[(2-methoxyphenyl)methylidene]-1-methyl-4,5-dihydro-1H-imidazol-4-one;4H-Imidazol-4-one, 2-amino-1,5-dihydro-5-[(2-methoxyphenyl)methylene]-1-methyl-
CAS No.855157-78-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBLHP857 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLGOT697 route compound structure diagram
    ACLGOT69760-27-5 In Stock
  2. Plus
  3. ACHPFS254 route compound structure diagram
    ACHPFS254135-02-4 In Stock
  4. Then
  5. ACBLHP857 route product structure diagram
    ACBLHP857855157-78-7
Inquiry

2. ACBLHP857 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBLHP857 route product structure diagram
    ACBLHP857855157-78-7
Inquiry

Comments (0)